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ABSTRACT

LUNG PARAQUAT CONTENT AND EFFECTS ON THE LUNG GLUTATHIONE ANTIOXIDANT
SYSTEM, NADPH, AND FOLYAMINES RESULTING FROM INTRAVENOUS
COINFUSION OF PARAQUAT AND PUTRESCINE TO RATS
by
Jacob R. Dunbar III

Paraquat was administered to male, Sprague-Dawley rats via
continoua infusion, at dosage rates of 250 (LoPQ) or 500 (HiPQ)
nmoles/hr for seven days. The purpose was to characterise the effects of
prolonged, low blood levels of the herbicide on selected lung
biochemical parameters. The efficacy of putrescine as an inhibitor of
pulmonary paraquat accumulation, in vivo, was assessed in these animals
by I.V. coinfusion of 2500 or 5000 nmoles putrescine/hr. Dose-dependent
levels of both paraquat and putrescine were achieved by 18 hours and
were maintained throughout the exposure period. Terminal lung paraquat
content was also dose-dependent and up to 18-fold greater than
corresponding blood levels, indicative of pulmonary accumulation of the
herbicide. Despite relatively high putrescine dosage rates, resulting
blood levels of this diamine were low and did not significantly alter
terminal lung paraquat content. No evidence of paraquat toxicity was
seen in LoPQ animals while frank toxicity was observed in the HiPQ
animals beginning between the fourth and fifth day. Qualitative
histopathological examination of the lungs revealed changes typical of
paraquat toxicity (e.g., interstitial edema, increase in type II cells)
resulting from HiPQ. Significant increases were found in levels of lung
glutathione and activities of the GSH peroxidase system enzymes,
glucose-6-phosphate dehydrogenase and GSSG reductase. These changes were
probably the result of paraquat-induced oxidant stress and increased
NADPH requirements. Elevations in lung putrescine, spermidine, and
ornithine decarboxylase activity were detected in HiPQ animals only, and
reflected the observed lung damage and/or resulting "proliferative"
state of the tissue rather than a direct response to paraquat. As in the
case of pulmonary oxygen toxicity, the increased levels of lung
polyamines may serve to mediate a reparative response to
paraquat-induced lung damage. The results demonstrate only a narrow
difference between a paraquat dose which produces no apparent lung
damage but stimulates components of the GSH peroxidase antioxidant
system and one which causes characteristic, paraquat-induced lung
damage. The experimental model employed here represents a useful means
to study subtle, paraquat-induced biochemical and morphological
alterations in lung by avoiding paraquat doses which rapidly produce
lung damage or are directly toxic to extrapulmonary tissues.
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CHAPTER 1
Introduction

Literature Review
Summary of biochemical mechanisms of paraquat toxicity
Paraquat (1, 1'-dimethy1-4, 4 ’-bipyridilium dichloride) Is a
quaternary blpyrldyl compound commonly used as a broad spectrum
herbicide.

It is notorious for its lung-specific toxicity which leads

to dramatic and Inexorable deterioration of lung function with fatality
resulting from respiratory failure.

The pulmonary toxicity of paraquat

is described as occurring In two phases (Heath and Smith, 1977).

The

first is a "destructive phase," characterized by damage to alveolar
epithelial cells and pulmonary edema.

Animals that survive this initial

phase progress to the "proliferative" phase which begins three to four
days after a single toxic dose.

During this time, profibroblasts begin

to migrate to the alveoli where they differentiate into fibroblasts,
with resultant development of lntraalveolar fibrosis.
The cyclic, reductlon-oxldatlon of this compound (Figure 1) Is
widely held to be the initiator of biochemical events leading to the
inevitable destruction of lung function.

This redox cycling of paraquat

Involves its enzymatic, one-electron reduction via NADPH-cytochrome
c reductase to a free-radical.

The paraquat free-radical is rapidly

reoxldized by molecular oxygen to the parent molecule with concomitant
production of a superoxide anion free-radical (Gage, 1968; Farrington et
al., 1973; Ilet et al., 1974; Bus et al., 1974 and 1975).

While no net

metabolism of paraquat occurs, there are two important consequences of
these reactions which are thought to contribute to the biochemical
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Figure 1. Reduction-Oxidation Cycling of Paraquat and Possible Consequences
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mechanisms of pulmonary toxicity (Bus and Gibson, 1984):
1.

production of superoxide radicals and other "activated oxygen"
species which may cause oxidant damage to structural and
functional macromolecules of the cell

2.

depletion of NADPH which Is required for biosynthetic pathways
such as fatty acid production and for antioxidant mechanisms
—

specifically, the glutathione peroxidase/glutathione

reductase system (Figure 1)
All tissues should be susceptible to this type of toxicity.
Indeed, kidney, gastrointestinal, and liver dysfunction can result from
paraquat intoxication (Gibson and Cagen, 1977).

However, In animals

surviving the Initial Insult, the "target organ" of paraquat toxicity is
the lung.

The two most widely supported explanations for this

lung-specific toxicity are
1.

the continuous exposure of the lungs to high oxygen tensions
relative to other tissues may result In a -more rapid redox
cycling of paraquat in the lung with concomitantly higher
rates of superoxide production and NADPH oxidation (Fisher et
al., 1973; Bus et al., 1977; Bus and Gibson, 1984)

2.

the ability of the lung to accumulate paraquat to a level much
higher than that of blood (Ilet et al,, 1974; Rose and Smith,
1977a and 1977b; Sharp et al., 1972; Litchfield et al., 1973;
VTltschl et al., 1977; Molnar and Hayes, 1971)

The Importance of pulmonary accumulation of paraquat to the
specificity of paraquat toxicity is Illustrated through contrasts In
toxicity of paraquat with that of the the related bipyridilium compound,

dlquat (Sharp et a l M

1972; Litchfield et al., 1973; Rose and Smith,

1977 and 1977b; Hitachi et al., 1977; Rose et al., 1974).

The acute

LD^g'a of these compounds are nearly equal (21 mg/kg) when administered
Intravenously to ratB (Sharp et al., 1972), but

dlquat does not produce

the lesion characteristically associated with paraquat Intoxication and
Is not actively accumulated into the lung (Rose and Smith, 1977a).

Proposed mechanism of paraquat uptake In lung
Rose jst al. (1974) demonstrated that pulmonary accumulation of
paraquat was an active, energy requiring process.
linear accumulation of methyl

They observed a

14
C-paraquat by rat lung slices from 30

minutes to two hours of Incubation.

The uptake was shown to be

energy-dependent since KCS plus lodoacetate prevented or Inhibited
paraquat accumulation when added either at the beginning of, or one hour
Into, Incubation.

Rotenone produced a similar inhibition of uptake.

An

Eadle-Hoffstee plot of their kinetics data indicated that the process

_5
was saturable with an apparent k

m

of 7 x 10

M and V
of 300
max

nanomoles paraquat/gram lung/hour.
Rose et al. (1976 ) found that the rate of paraquat accumulation
into rat lung In vivo was about 1/7 of that predicted by their In vitro
studies.

They attributed the observation to the presence of an

Inhibitor(s) of paraquat uptake In the circulation.

Locke at a l .

(1976), subsequently found several endogenous and exogenous compounds
capable of reducing paraquat accumulation by rat lung slices.
Smith and Wyatt (1981) discovered that the endogenous diamine,
putrescine, on important modulator of cellular functions, inhibited
paraquat accumulation by rat lung slices In a concentration dependent

manner.

They also found that putresdnp was, itself, accumulated by

lung slices.

In comparing the kinetics of lung accumulation of

putrescine with those of paraquat, several similarities were
demonstrated (Smith and Wyatt, 1981).

Putrescine uptake was linear,

reduced with rotenone or KCN plus iodoacetate, enhanced in a sodium-free
medium, and not Inhibited by ouabain.

From their experiments they were

able to conclude that paraquat is taken up by the lung by a mechanism
intended for the uptake of endogenous diamines and polyamines.

The

Inhibition of paraquat uptake by lung slices is mediated through
competition with putrescine at the site of uptake (apparent K^'s of
uptake - putrescine - 7jiM; paraquat « 70pM).
Paraquat uptake was reduced in lung slices taken from rats
receiving prior Intravenous paraquat (27 mg/kg) (Smith et al, 1976).
Evidence of damaged type I and type II alveolar epithelial cells in
those lungs suggested a major site of paraquat uptake Is the type I and
II cells.

Smith and Wyatt (1981), using the same dosing protocol,

removed lungs from rats 2 and 24 hours post-paraquat treatment and
measured uptake of putrescine and paraquat In slices of these lungs.

As

judged by electron microscopy, at two hours there was no evidence of
damage to the alveolar epithelial cells and also no significant
reduction in accumulation of putrescine or paraquat.

At 24 hours there

was evidence of morphological damage to these cells and both paraquat
and putrescine uptake were decreased by approximately 35 percent.
results suggested

These

that the population of cells Into which paraquat and

putrescine are accumulated is, at least in part, type I and type II
alveolar epithelial cells.
In 1982, Smith and Wyatt reported that the polyamlnes, cadaverine,
spermidine, and spermine are accumulated by lung slices by the same
mechanism described for putrescine (Smith and Wyatt, 1981).
suggested that the

They

reason for pulmonary uptake of paraquat by this

mechanism is the similarity in the separation of the quaternary nitrogen
atoms of paraquat and the amino groups of putrescine and other
polyamlnes.

This would require the receptor of the transport mechanism

to be based on structural elements of a potential transportable
molecule.
Structure/activity correlation studies of Rosb and Krleger (1981)
suggest that requirements of a compound to effectively occupy or block
the receptor mediating this uptake Include (1) two or more positively
charged nitrogens, (2) maximum positive charge, (3) an apolar group
which increases lipid solubility, and (4) minimum steric hindrance near
the nitrogen atoms.

Gordonsmlth et al. (1983), using rat lung slices,

supported these requirements and made the additional generalization that
for a compound to be an effective inhibitor of the
dlamlne/polyamlne/paraquat uptake system, the two nitrogen-containing
cationic centers should be separated by at least four methylene groups.
To date, studies on the nature of the pulmonary uptake of paraquat
have largely been performed using lung slices, an in vitro model with
clear limitations.

In the lung slice systeml normal endothelial

barriers between circulating paraquat and its purported site of uptake
(i.e., alveolar epithelial cells) are not intact and paraquat in the

incubaclon medium has free access to the site of uptake.

Attempts have

been made to address this problem via the isolated, perfused lung.
Rannel'a et al. (1985) corroborated the findings of Forman et al. (1982)
by demonstrating a biphasic tlme-course of pulmonary accumulation of
paraquat by perfused rat lungs from the perfusing medium.

Phase one

occurred over the first 60 minutes of perfuBion and was characterized by
a slow, concentration-dependent accumulation of paraquat into the lung.
This is believed to reflect passive diffusion of paraquat from the
perfusate through the endothelium.

After 60 minutes the rate of

paraquat uptake was markedly increased, concentrative in nature, and
saturable with increasing perfusate paraquat concentrations.

The

Increased rate of uptake was not associated with Increased tissue
permeability resulting from tissue damage.

This second phase of

paraquat uptake was markedly inhibited by coperfusion with methylglyoxal
bis(guanylhydrazone) (MGBG), a nonmetabolizable polyamine substrate
analogue (50:1 - HGBG:PQ).

Thus, these data support the occurrence of a

polyamine-lnhlbitable, active accumulation of paraquat into the Intact
lung.
It is important to consider that the concentration of paraquat in
the lung will be determined not only by the rate of accumulation into
the tissue, but also by the rate of efflux.

Putrescine increases efflux

of paraquat from lung tissue as well as Inhibits its uptake.

Lung

slices taken from rats two hours after dosing with paraquat were
incubated with putrescine, resulting in a decrease in the half-life of
paraquat in the lung from 17.2 to 8.6 hours (Smith et al., 1981).

8
Importance of putrescine and other polyamlnes In paraquat toxicity
Putrescine Is the first compound formed In the polyamine
biosynthetic pathway (Figure 2).
ornithine decarboxylase (ODC).

It Is produced from ornithine via
Through sequential propylamine additions

from S-adenosyl methionine, spermidine and spermine are synthesized from
putrescine.
Although their biochemical function Is not yet understood, a large
body of evidence Implicates polyamlnes as having a major role in cell
growth, proliferation, and differentiation (RusBel and Snyder, 1968;
Heby, 1981; Pegg et al., 1982), and enzyme regulation (Dodds et al.,
1986).

Sharp Increases In the activity of ODC and rates of cell

proliferation are seen with organ growth (Russel and Snyder, 1968);
wound healing (Mitzutanl et a l ., 1974), and repair of liver (Katsul et
a l ., 1981) and Intestinal mucosa (Luk et al., 1980).

The involvement of

polyamlnes in growth and proliferative functions may be especially
pertinent with regard to paraquat toxicity because of the Initial
cellular destruction and the subsequent Interstitial and intraalveolar
proliferation of fibroblasts.

It has even been suggested that

putrescine may serve as a growth factor for fibroblasts (Ham, 1964;
Pohjanpelto and Raina, 1972).
In 1982, Khanna et al. demonstrated the ability of putrescine,
spermidine, and spermine to prevent paraquat-induced lipid peroxidation
and superoxide dlsmutase induction in incubations of rat lung slices or
in lungs of rats parenterally dosed with paraquat.

They did not relate

these findings to passible inhibition of paraquat accumulation Into the
lungs, but explained their results on the basis of "membrane-

9
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DECARBOXYLASE
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NH 2CCH 2] ^JH CCH 2 ] 4NH tCH 213NH 2

Figure 2. Polyamine Biosynthetic Pathway.

10
stabilizing" effects of polyamlnes and/or their superoxide scavenging
effects (Vanella et al., 1979 and 1980).

This potential free radical

scavenging property of polyamlnes could be of benefit in paraquat
toxicity.
Exposure of rats to 85X oxygen resulted In a marked elevation of
lung ODC activity which was maintained through nine days of oxygen
exposure (Hacker et al., 1983).

Lung putrescine content demonstrated a

similar elevation which also persisted throughout the exposure.

Lung

content of spermidine and spermine were similarly increased, but not
until later (5 days of exposure).
Thet et al. (1984) investigated alterations in rat lung ODC
activity and polyamine levels during the repair phase of oxygen-induced
lung Injury.

Immediately post-injury both the activity of ODC and

levels of putrescine were markedly Increased in lungs.

Ornithine

decarboxylase and putrescine levels continued to rise several days
post-injury, accompanied by Increased levels of spermidine and spermine
later in the repair phase,

Morphometric analyses showing elevations in

these parameters during repair could be correlated with a doubling of
pulmonary endothelial cells and capillary surface area

sb

well as a

2.3-fold increase In the number of type II epithelial cells.

Treatment

of rats with dlfluoromethylornithlne, an inhibitor of ODC, resulted in
suppression of polyamine levels occurring during the repair phase and
comparably reduced the above morphometric parameters.

11
Effects of paraquat in the Isolated,
perfused rabbit lung
Because of Its ability to produce superoxide radicals with
resultant Increases in

and other toxic oxygen radicals,

paraquat-induced alterations in the redox status of glutathione (GSH reduced; GSSG - oxidized; TLG •* total lung glutathione) in the isolated,
perfused rabbit lung have been Investigated (Dunbar et al., 1980, 1981,
1984, and 1985).

GSH serves as a major aqueous antioxidant mechanism in

the cell because of its inherent reducing capacity and its role In the
GSH peroxldase-enzyme system (Figure 1).

The enzymes involved in this

system are GSH peroxidase which uses GSH as a cofactor in reduction of
hydrogen peroxide and lipid hydroperoxides, GSSG reductase which reduces
GSSG back to GSH, and glucose-6-phosphate dehydrogenase (G6PD) which
supplies NADPH required by GSSG reductase as a source of reducing
equivalents.
Thirty minute perfusion of Isolated rabbit lungs with paraquat
results in a significant increase In levels of lung GSSG (Dunbar et al,,
1984).

This paraquat-induced GSH oxidation is potentiated by hyperoxic

ventilation of the lungs.

GSSG efflux, another indicator of oxidant

stress, is also Increased by paraquat perfusion (Dunbar et^ al., 1984).
Paraquat has been shown to induce activities of pulmonary GSSG
reductaBe, G6PD (Bus et al,, 1976), and GSH peroxidase (Reddy et al.,
1977) and increase levels of GSH (Keeling and Smith, 1962) in rats.

In

addition to the Increased specific activity of lung G6PD, paraquat
increases the flux of glucose through the pentose phosphate pathway (the
rate-limiting enzyme being G6PD) in Isolated rat lungs (Bassett and

12
Fisher* 1978), lung slices (Rose et al.> 1976), and Isolated granular
pneumocytes (Fisher and Relcherter, 1984).

The induction of these

enzymes has potential importance in augmenting the antloxldant capacity
of a tissue.
Objectives
There were two major objectives of this research.

The first was to

characterize biochemical effects elicited by prolonged, continuous,
lov-dose (In terms of rate) paraquat administration on pulmonary
glutathione status, enzyme activities of the GSH peroxidase antloxldant
system, and normal lung levels of putrescine, spermidine, and spermine
In rats.
The effects of this "low-level" paraquat exposure on lung
glutathione and the glutathione peroxidase antloxldant system should
have Implications concerning the capacity of the lung to maintain or
enhance this defense mechanism against a level of paraquat exposure
which may not be acutely toxic
with prolonged exposure.

but may carry the potential for damage

An important question is whether or not the

lung can maintain this protective mechanism In an induced state.
Alternatively, will prolonged exposure to even low doses of paraquat
result in decreased lung glutathione and impairment of the glutathione
peroxidase system?
Based on what is known about the role of polyamlnes in repair of
tissue injury, increases in lung polyamine levels resulting from
exposure to apparently subtoxlc doses of paraquat may suggest the
occurrence of limited cellular damage that Is manageable by available
repair mechanisms and, therefore, not manifested as an observable

13
response.

As In the case of oxidant protection afforded by the GSH

peroxidase system, Increased polyamine levels may be associated with
augmented repair potential until finally the rate of damage exceeds the
capacity of the repair mechanisms.
The second objective was to determine If coadministration of
putrescine would result In a decrease in the levels of paraquat detected
In the lungs at sacrifice.

Because of the Importance generally ascribed

to pulmonary accumulation of paraquat in the realization of its
toxicity, there could be potential therapeutic benefit In the inhibition
of paraquat uptake into the lung or increase In Its efflux from the
lung.

Demonstration of decreased lung paraquat levels with putrescine

coadministration could greatly contribute to this end.

Because the

literature suggests a potential antloxldant effect of exogenous
putrescine, coadmlnlstratlon of the diamine might provide some direct
protection to the lungs from paraquat-generated oxidants.

This might be

observable as an attenuation of the biochemical alterations usually
attributed to paraquat and paraquat-induced production of oxygen
radicals.

Hypotheses
The study.reported here encompasses three primary hypotheses:

(1)

Continuous coadmlnlstratlon of putrescine to rats receiving parenteral
paraquat will result In a decrease In the concentration of paraquat
detected In lung tissue.

(2) Paraquat will cause alterations in normal

levels of polyamlnes in the lung in a manner similar to that observed to
resulting from oxygen exposure and in recovery from oxygen-induced
pulmonary Injury.

(3) Continuous infusion of paraquat at "sub-toxic"
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doses will result In Induction of lung glutathione and the GSH
peroxidase system.

Chapter 2
Materials and Methods

Preparation of Treatment Solutions and Osmotic Pumps
The delivery system for paraquat and putresclne used In this study
was the Alzet*9, Model 2ML1 osmotic pump (Alza Corporation, Palo Alto,
CA).

All pumps used In this experiment were from the same lot (#5258A)

and provided a pumping rate of 11.5 t 0.3 pl/hr for seven days.

The

filling volume for this lot was 2037 t 34 pi.
Solutions of paraquat (methyl vlologenOH^O - Sigma Chemical, St.
Louis, MO.; lot #54F-3568) and/or putresclne dlhydrochlorlde (Sigma; lot
#111F-0106) were prepared In sterile Ringers solution In concentrations
required to provide the proper dosage based on the delivery rate of the
osmotic pump.

Coadmlnlstratlon of both compounds via one osmotic pump

was considered acceptable when a solution of paraquat and putresclne
(approximately 30 and 50 mM, respectively), kept In the dark at 37°C,
exhibited no apparent degradation of either compound after seven days.
The concentrations required to provide delivery rates of 250 and 500
nmoles paraquat/hour were 21.74 and 43.48 mM, respectively.

For

putresclne delivery of 2500 and 5000 nmoles per hour, the respective
solutions contained 217.39 and 434.78 mM putresclne dlhydrochlorlde.
After preparation, the solutions were filtered through a 0.2 micron
filter and stored refrigerated and In the dark.
On the morning of the day the pumps were to be implanted, they were
filled to capacity with one of the previously prepared solutions of
paraquat and/or putresclne or with vehicle only for controls.

A nine

centimeter length of sterile vinyl tubing (0.028" I.D. X 0.046" O.D.)
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was attached to the delivery port of each pump* which was then placed In
Individual test tubes containing 0.92 sterile saline.

They were

Incubated at 37*C for at least four hours as suggested by the
manufacturer to Insure that the pumps would provide nominal and uniform
delivery rates immediately after Implant.

Animals and Treatment
Forty-five chronic disease-free, male Sprague-Dawley rats (Charles
River, Wilmington, MA.) weighing from 350 to 400 grams were randomly
divided into nine groups of five animals each. Another group of five

*>
rats was Included in the study to serve as controls for any potential
decrease in food consumption of the treated animals.

Depending on

assigned treatment group, the rats received one of nine possible dosage
combinations of paraquat and putresclne.

The treatments were comprised

of either zero, 250 or 500 nmoles paraquat/hour coadministered with
either zero, 2500, or 5000 nmoles putresclne/hour (Table 1).

The route

of administration was Intravenous via subcutaneously Implanted osmotic
pumps.
Each day, for five consecutive days, one animal from each of the
nine treatment groups was anesthetized with five milligrams sodium
pentobarbital per 100 grams body weight (X.P.).

A 1.5 cm Incision was

made through the skin of the neck and the right, external jugular vein
exposed by blunt dissection.

The vein was ligated cranlally with a 4-0

silk ligature and cannulated with the primed delivery cannula of Che
appropriate osmotic pump.

The cannula was advanced to the approximate

level of the right atrium and secured with another silk ligature passed
around the vein below the point of insertion.

The body of the pump was
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Table 1. Experimental Design

Putrescine Dosage Rate
(naoles/hr)
Paraquat Dosage Rate
(nmoles/hr)

0

2500

5000

row n

0

n = 5

5

5

15

250

5

5

5

15

500

5

5

5

15

15

15

15

45

column n

Inserted through the same Incision, advanced over the right shoulder and
positioned subcutaneously In the subscapular area.

This pump placement

was made via a subcutaneous tunnel formed with the tip of a large, blunt
hemostat.

Following pump implantation, the skin incision vaB closed

with running, 4-0 nylon suture.
Immediately after pump implant, the rats were weighed and placed in
individual cages where they were maintained on a 12-hour light/dark
cycle. Food consumption (Wayne Lab-Blox, Chicago, IL) and animal weight
and condition were recorded dally for the duration of the exposure
period of 162 hours (approximately one week).

Food consumption of the

food-limited control (FLO) animals was roughly matched with the average
daily food consumption of the animals given 500 nmoles paraquat/hour
which exhibited pronounced anorexia.

One rat from each group was

maintained in a metabolism cage (Bias Labs, Lansing, HI) for the entire
exposure period to allow collection of total urine output.
Additionally, blood samples (up to one ml) were collected from these
representative animals at 18, 42, 66, and 114 hours of exposure.

The

samples were collected via tall cut into heparlnized microcentrifuge
tubes and diluted to twice their volume with isotonic saline to insure
adequate volume for paraquat and polyamlne measurements.

Urine and

blood samples were stored at -20°C until analyzed.

Sacrifice and tissue preparation
Rats were sacrificed on the seventh day of exposure.

The rats were

anesthetized with sodium pentobarbital as described above and blood
collected by cardiac puncture into seven ml, heparlnized test tubes.
The blood thus collected was stored at -20°C.

The thorax was opened and
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the lungs flushed for 30 seconds with 25 ml Ice cold 0,9% NaCl via a
catheter placed In the pulmonary artery.

The appearance of the lungs*

liver* kidneys* and heart were noted prior to their rapid removal to
ice-cold 0.9% NaCl.

The organs were blotted and their weight recorded.

Liver* kidney* and heart were wrapped in aluminum foil* labeled* frozen
In liquid nitrogen* and stored at -80*C for subsequent biochemical
analysis.
The basilar half of the right upper lobe of the lungs was placed In
10% phosphate-buffered formalin which was bubbled with CO,, to promote
inflation of the specimen.

Both hematoxylln-eosln-* and Masson's

trlchrome-stalned* five micron sections of this lobe were submitted for
histological evaluation.

The sections were coded to insure that the

examining pathologist was "blind" to treatment group.

The remaining

portion of the lobe was frozen in liquid nitrogen for measurement of
NADPH.
The remaining lung tissue was rewelghed and homogenized in 10
volumes of ice-cold 0.1S M NaCl - 0.0S H KH^PO^ pH 7.2, buffer (PBS)
with a Brlnkmann Palytron (PCU-2-110* Brlnkmann Instruments* Westbury,
NY).

Aliquots of homogenate were stored at -20°C for analysis of lung

polyamines and paraquat, respectively.

The remaining lung homogenate

was diluted with an equal volume of the cold PBS and vigorously
vortexed.

Six ml of diluted homogenate was centrifuged at 23*000 x g

for 30 minutes at A°C.

The resulting post-mltochondrlal (P-M)

supernatant was used for enzyme analysis.

The remainder of the diluted

lung homogenate was used for glutathione determinations.

Biochemical analyses
All biochemicals used In the following analyses were purchased from
Sigma Chemical Company (St. Louis, HO).

Ornithine (DL-[1-^CJ) was

purchased from Hew England Nuclear Research Froducts(Boston, HA).
Scintillation-, and HPLC-grade solvents were purchased from Fisher
Scientific (Norcross, GA).

All other chemicals were reagent grade and

obtained through various commercial sources.
On the day of sacrifice, one ml of diluted lung homogenate
(described above) was deprotelnlzed with four ml of 1DZ trichloroacetic
acid (TCA) for measurement of total lung glutathione (TLG).

One ml of

this homogenate wsb also added to 2.5 mg of N-ethylmaleimide (NEM),
vortexed, and left at room temperature for one hour to irreversibly bind
reduced glutathione (GSH).

This sample was then deprotelnlzed with four

ml of 10% TCA for analysis of the unconjugated oxidized glutathione
(GSSG). Both preparations were centrifuged at 3000 x g for 10 minutes
and the respective supernatants extracted 10 times with equal volumes of
water-saturated diethyl ether to remove TCA and excess NEM.
Total glutathione and GSSG were measured. In duplicate, in the
appropriate samples by the spectrophotometrlc method of Tietze (1969).
The method measures at 412 nm and 37cC the rate of formation of the
chromophore, 2-nitro-5-thiobenzoic acid, which results from the reaction
of S.S'-dithlo-bis-Z-nltrobenzolc acid (Ellman's reagent, DTNB) with
GSH.

This reaction Is coupled to the GSSG reductase-catalyzed reduction

of GSSG to GSH.

The assays were performed In cuvettes containing 1.25 U

glutathione reductase, 120 pM DTNB, 20 pH NADFH, and 10 - 50 pi of
tissue prep or standard GSH+GSSG In 1.0 ml of 0.1 M Na/K phosphate, 5.0
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mM EDTA buffer, pH 7.S.

Under these conditions the rate of chroraophore

production was proportional to the amount of GSH and GSSG present In the
reaction mixture.

Kates were recorded against a sample blank and GSH

and/or GSSG content calculated by comparison to a standard curve.
The activity of ornithine decarboxylase (ODC) van determined In
triplicate within three hours of sacrifice by the method of Russel and
Snyder (1968) as modified by Lau and Slotkln (1979).
measures the amount of

This method

14
14
CO^ liberated by ODC from dl-1- C-ornlthine.

A 0.9 ml aliquot of the lung P-M supernatant was incubated with 1.8 mM
dithlothreltol and 50 pM pyrldoxal phosphate (1.0 ml total volume) In a
25 ml Erlenmeyer flask equipped with a rubber stopper supporting a
suspended polyethylene center well (Kontes Glass, Vineland, NJ).

The

center well contained 0.6 ml hyamine hydroxide (1.0 M In methanol) to
absorb liberated

14

CO^.

The flasks were agitated for ten minutes at 37°C in a shaking water
bath.

After thlB equilibration period, 0.5 uCi of DL-l-

14

C-omithlne

(specific activity 57.6 mCl/mmole) substrate was Injected into the
system via a stoppered sidearm of the flask (final ornithine
concentration - 10.5 pM).

The flasks were agitated for 30 minutes,

after which time 1.0 ml of 2.0 M citric acid was injected through the
Bidearm to stop the reaction.

The mixture was shaken another 30 minutes

at 25"C to allow complete absorption of

14
CO^ by the hyamine hydroxide.

The center wells were removed from the flasks and placed In glass
scintillation vials containing 15 ml of 0.42 2,4-diphenyloxazole and
0.01% B~bls-(2-phenyloxazole) benzene in scintillation grade toluene.
The vials were then assayed for radioactivity In a liquid scintillation
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spectrometer (Beckmann, Model LS 9800). A TCA-injected enzyme blank was
Included In each assay run to determine radioactivity from
non-enzymatlcally liberated

14

CO^ or other sources.

Background counts

were also made In vials containing only scintillation fluid.
were converted to

Counts

dlslntlgrations per minute (corrected for quenching)

and ODC activity reported as pmoles

liberated/lung/hour.

The activities of glucose-6-phosphate and 6-phosphogluconate
dehydrogenase (G6PD and 6PGD), GSSG reductase (GR) and glutathione
peroxidase (GP) were measured spectrophotometrically, In duplicate, at
37°C in the lung P-M supernatant by recording changes In 340 nm
absorbance of the appropriate reaction mixture.

The absorbance change

w s b due to the rate of reduction of NADP by G6PD and 6PGD (Beutler,

1975) or oxidation of HADFH by GR (Horn, 1965) and GP (Little et al.,
1970).

The activities were calculated using the molar extinction

coefficient of

NADF(H) at 340 nm (6.22 x 10^).

The colorimetric method of Slater and Sawyer (1962) was employed
for measurement of lung NADPH.

Portions of rat lung (100-300 mg) that

had been previously frozen in liquid nitrogen were homogenized In hot
0.05 M HaOH containing 0.42 mM tryptophan to prepare a

12.52 (w/v)

homogenate and boiled for 2 minutes.

then Iced for 15

minutes and

The samples were

neutralized with 1.0 M Kl^PO^, followed by centrifugation

at 4°C for 30 minutes.

Aliquots (0.05-0.10 ml) of the clear supernatant

were plpeted into 1 cm u.v.quartz cuvettes containing 30 uM
dlchlorophenol-lndophenol (diluted from 1.75 mgZ stock solution prepared
fresh each day).

Additionally, each cuvette contained

glucose-6-phasphate, 65 pM phenazine methosulfate, and

2 mM
0.15-0.20 ml of

0.1 M Trls buffer, pH 8.0.

The contents were mixed and the absorbance

changes at 600 nm followed for a period of five to ten minutes, until a
stable baseline was obtained.

Three-tenths unit of G6P0 was then added

and the resultant rate of absorbance change (linear for 2-4 minutes) was
compared to that obtained with 100, 200, or 500 pmole standards of
NADPH.

The amount of NADPH present In the sample aliquot was converted

Into NADPH/lung by using a correction factor dependent upon the total
volume of neutralized NADPH homogenate prepared and the ratio of total
lung weight to the weight of the sample homogenized, as given above.
Paraquat was measured, In duplicate, spectrophotometrlcally In
blood, urine, and tissue homogenates by modifications of the method of
Knepll (1977).

For determination of paraquat In urine, 20 pi of urine

was diluted to 2.0 ml with water.

To the dilute urine was added 0.2 ml

of alkaline dlthlonlte solution (0.2 g sodium dlthlonlte In 10 ml 1.0 N
NaOH).

The resulting blue color was read at 396 nm against a blank

without alkaline dlthlonlte. Urine paraquat was calculated by comparison
to a paraquat standard curve prepared from serial dilution of paraquat
In water with concentrations encompassing the range of diluted samples
(0.5 pg/ml - 8.0 pg/ml).
For analysis of blood paraquat, one ml of blood and one ml of water
were added to 2.0 ml chlorofornwethanol (4:1,V:V) and vigorously mixed.
To this mixture was added 1.2 g ammonium sulfate followed by additional
mixing.

The deprotelnlzed blood extracts were then centrifuged at 3000

x g for 10 minutes.

Alkaline dlthlonlte (0.1 ml) was added to one ml of

the supernatant and the absorbance recorded versus supernatant without
dlthlonlte.

The calibration curve was constructed from standard
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solutions of paraquat (0.5 pg/ml - 4.0 pg/ml) prepared in control rat
blood.
To determine paraquat in lung, 2.0 ml of the previously prepared
10Z lung homogenate vaa mixed with 2.0 ml of chloroform:ethanol and 1.2
gm ammonium sulfate and centrifuged at 3000 x g for 10 minutes.
Paraquat was measured in the supernatant as described above for blood.
The calibration curve was performed in pooled, control lung homogenates
spiked with paraquat concentrations of 0.5 - 8.0 pg/ml.
Paraquat levels were determined in like manner in PBS homogenates
of liver, kidney (0.3-0.6 g tissue/ml), and heart (0.2 g tissue/ml) with
paraquat standard curves constructed from the respective,
paraquat-spiked, tissue homogenates from control animals.
Dansylatlon of the urine and tissue samples for HPLC analysis of
polyamines was carried out, in duplicate, by the method of Fleishcer and
Russell (1975). One ml of a 20-fold diluted urine sample, one ml of
blood (125 pi in serial blood samples), and samples of tissue
homogenates containing approximately 200 mg tissue (in 0.5 - 2.0 ml
homogenate) were deprotelnlzed with perchloric acid (PGA) to provide a
final 0,2 H PCA concentration.

Forty nmoles of dlethylamine (DEA) were

added as an Internal standard to each sample.

After vigorous mixing the

deprotelnlzed samples were centrifuged at 3000 x g for 10 minutes.

A

known volume of the resulting supernatant was transferred to tubes and
dansyl chloride in acetone (2.7 mg/ml) was added in the amount of 0.25
ml/ml supernatant.

The pH of the dansylatlon mixture was adjusted to

9.0 ± 0.5 with saturated sodium carbonate (200 - 400 pi, depending on
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sample volume).

The samples were then Incubated In the dark at room

temperature for four hours.
Following the Incubation period, the acetone was evaporated

under

a stream of nitrogen and the sample extracted with 2.0 ml benzene.

The

mixtures were centrifuged (3000 x g, 10 minutes) and 0.4 ml of the
benzene layer removed and placed In HFLC sampling vials.

The benzene

was evaporated to dryneas overnight and then reconstituted with 2.0 ml
of HPhC grade chloroform.
Standards of putresclne dlhydrochlorlde, spermidine,
trlhydrochlorlde, and spermine tetrahydrochlorlde containing
concentrations of from one to 200 nmoles of each compound/ml plus 40
nmoles DEA/ml were prepared and dansylated by the same method.
Standards and samples were treated Identically throughout this
derlvatizatlon process.
Analysis of the fluorescent, dansylated polyamine standards and
TM

tissue preps were performed on a Waters

(Milllpore Corporation,

Milford, MA) HPLC system equipped with an automatic sampler (WlBp^*
710B).

The solvent system used consisted of chloroform:Isopropanol

(100:1) (both HPLC grade) with solvent flow maintained at one ml/mlnute.
TM

A Waters

TM

pPoraail

v

TM

column (8 mm x 10 cm) in a Waters

Radial

Compression Module (RCM-100®) was uBed for separation of the polyamlne
derivatives.

Eluted peaks were detected by a Waters

TM

Model 420

Fluorescence Detector equipped with a 365 nm bandpass filter for
excitation and 495 nm longpass filter for emission wavelengths.
Protein measurements were made by the method of Lowry et al (1951).

Statistical analyses of the data was by two-way Analysis of
Variance.

Upon detection of a treatment resulting in significantly

different data, a Duncan's Multiple Range test was used for comparison
of treatment group means.

These analyses were performed using the

Statistical Analysis System (SAS)C
NC).

software (SAS Institute, Inc., Cary,

Comparisons of data obtained from Food-limited Control (FLC)

animals with that of other treatment subgroups were performed by
Student's t-test.

CHAPTER 3
Results

Animal condition, body weights, and food consumption during
Infusion period
All animals except for those receiving high-doae (300 nmoles/hour)
paraquat (H1FQ) tolerated their respective treatment combinations veil,
as judged by behavior and outward appearance.

Rats given either zero

(OPQ) or low-dose (250 nmoles/hour) paraquat (LoFQ), regardless of
putresclne dosage, appeared healthy, had comparable food consumption
(Figure 3), maintained or had slight increases In their body weight
(Figure 4), and seemed to exhibit normal activity throughout the almost
seven days (approximately 162 hours) of paraquat and/or putresclne
Infusion.
As a group, however, rats administered H1PQ began to show outward
signs of distress, generally between the fourth and fifth day of
exposure.

This usually began as a dark, crusty discharge around the

nose, progressing to rapid, shallow breathing, lethargy, and decreased
food consumption. Animals most affected appeared emaciated and pale with
some indication of cyanosis by the end of exposure.

Food consumption

had ceased; there was little voluntary activity; breathing was rapid,
shallow, and obviously labored; and some exhibited piloerection.
Throughout the period of Infusion there was a progressive decrease in
body weight In these animals (Figure 4).

Food consumption was lower in

the HiPQ groups compared to other treatments beginning between day two
and three with a more marked decline In mean food consumption beginning
between days four and five (Figure 3).
27
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Figure 3. Daily Food Consumption
Mean daily food consumption (grams) ± standard deviation of rats
given no paraquat (o) (n“ 15), 250 nmoles paraquat/hour (o) (n“15), 500
nmoleB paraquat/hour (•) (n"14), and food limited control (FLC) animals
(x) (n“5). There was no variation in food consumption of the FLC animals
since they ate all the food made available to them. These data are
presented as a function of paraquat dosage only since putrescine
administration had no effect on food consumption.

DAILY FOOD CONSUMPTION (GRAMS)

to

cn

to

29

Figure 4. Daily Changes in Rat Body Heights
Hean daily body weight as percentage of pre-operative weight ±
standard deviation in rats-given no paraquat (o) (n«15), 250 nmoles
paraquat/hour (e) (n*«15)( 500 nmoles paraquat/hour (•) (n“14), and food
limited controls (FLC) {*) (n**5). These data are presented as a function
of paraquat dose only since putrescine administration had no effect on
food consumption.
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Due to the extremely poor appearance (at day five) of one animal in
both the 500 nmoles paraquat/hour + zero putresclne (OFTC) and 500
nmoles paraquat + 5000 nmoles putrescine/hour (UiPQ + HiPTC) subgroups*
one additional rat was added to both groups in an attempt to assure
survival of five animals per treatment group.
Two animals in the K1PQ + OPTC group were found dead before
conclusion of the exposure period; one on the sixth and one on the
seventh day of exposure* leaving four surviving animals in this group.
Necropsy of the spontaneously-dying animals revealed pleural effusion
fluid (approximately one to two ml) in the thoracic cavity and lungs
which were large, plum colored, and resistant to collapse.

The relative

weights (organ weight/body weight x 100) of the lungs of these two
animals were increased to 1.56 and 0.81* respectively ( compared to 0.27
+ 0*03 in the OPQ + OPTC group). Compared to control (i.e., the OPQ +
OPTC group) the relative weights of livers, kidneys, and hearts of the
respective dead animals were Increased 4.27 and 31.87, 51.97 and 54.37*
and 130.07 and 33.37, respectively.
One of the animals in the H1PQ + U1PTC treatment group died between
day six and seven of exposure.

The organs appeared as described above.

The relative lung weight was Increased to 1.46 (4417 of control) and the
relative weights of liver, kidney, and heart were also Increased 25.47*
75.37, and 143.07 over control, respectively.
Food consumption in the Food-limited Control group (FLC) was
maintained at a steadily decreasing level In on attempt to roughly match
the highly variable food consumption observed in the HiPQ groups (Figure
3).

The body weight loss of the FLC animals reflected their impaired
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nutritional status and was slightly greater, on average than that of the
HiFQ animals (Figure 4).

Dally paraquat and putresclne concentration in blood and
urine of representative animals from each treatment group
Figure 5 shows the blood paraquat concentration at approximately
18, 42, €6, 114, and 162 hours, post-pump Implant, In rats maintained In
metabolism cages and administered paraquat.

The blood levels Indicated

that paraquat was maintained at steady blood concentrations by the
method and route of administration employed In this study.

In these

representative animals, those given LoPQ, regardless of putresclne
dosage, maintained mean blood levels of paraquat which ranged from 0.82
± 0.23 to I.52 ± 0.17 nmoles paraquat/ml blood (n-3).

Blood

concentrations of paraquat In the animals administered H1PQ were
maintained, as expected, In a range double that measured In the LoPQ
animals [2.36 (n-1) to 3.03 + 0.69 (n**3) nmoles paraquat/ml blood].

As

In the LoPQ animals, putresclne administration had no effect on blood
paraquat concentration In animals given H1PQ.
The average putresclne blood level maintained In each of the
representative animals was, also, reflective of administered dose (Table
2).

However, the animal representing both the UiPQ + OPTC and H1PQ +

H1PTC groups showed great variability in this data primarily due to one
outlying data point.

Putresclne analysis In these temporal blood

samples did not appear to provide the same sensitivity as the terminal
blood samples, as evidenced by lack of detection of putresclne in OPTC
animals.

u

to

Figure 5. Temporal Blood Paraquat Concentration
Blood paraquat concentrations (nmoles/ml ± standard deviation) in representative animals given
500 nmoles paraquat/hour (*) (n=3) were maintained at significantly higher levels (P < 0 . 0 5 by Student's
t-test) than those given 250 nmoles paraquat/hour (o) (n*3). There were no differences in blood
concentration of paraquat with putrescine coadministration, therefore, the data points represent the mean
standard deviation of the three animals given the stated dose of paraquat regardless of which of the three
different levels of putrescine was administered (i.e., 0, 2500, or 5000 nmoles/hour).
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Table 2. Averge Daily Blood Putrescine Concentration*

Putrescine Dosage Rate
(nmoles/hr)
Paraquat Dosage Rate
(nmoles/hr)

0

2500

5000

0

ND

3.93 + 1.65
(5)

15.41 ± 17.95a
(5)

250

ND

4.59 ± 0.66
(4)

8.44 ± 1.53a
(5)

500

ND

5.66 + 2.30
(5)

29.22 ± 33.39
(4)

*Data are expressed as average daily blood putrescine
concentration (nmoles/ml) in individual rats for the duration of
treatment±standard deviation. Numbers in parentheses indicate number
of daily determinations comprising the average.
aThe high standard deviation in these animals can be accounted
for by one out-of-range data point in each group.
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Daily urinary excretion of both paraquat and putrescine
demonstrated a steady, dose-dependent elimination of both compounds
(Figure 6),

There was no apparent effect of one compound on the urinary

excretion of the other in these representative animals.

The total

urinary excretion of paraquat in these animals amounted to 81 + 18%
(n**3) and 78 + 8.0% (n**3) of administered dose for LoPQ and H1PQ groups,
respectively.
± 4.0%

Total urinary excretion of putrescine represented only 13

(n-3) and 11 t 3.0% (n**3) of the total administered putresclne

in animals given LoPTC (2500 nmoles/hour) and H1PTC (5000 nmoles/hour),
respectively.

Since putrescine is an endogenously produced compound,

not all of the excreted putresclne could be attributed to that which was
administered.

In animals not given putresclne the total urinary

putresclne excretion reached approximately 20 nmoles by the end of the
exposure period.

Body and organ weights and gross pathology
Regardless of putresclne dosage, the body weights of LoPQ and UIPQ
rats, at sacrifice, proved to be 93.7% and 78.5% (F<0.05),
respectively, of rats given OPQ (Figure 7).

The apparent decrease seen

in the LoPQ group was not a true decrease because the average
preoperative weight of these animals was 95.7% (P<0.05) of the rats
assigned to the OPQ group.

The average terminal body weight of the FLC

animals waB 76.8% of the OPQ group (P< 0.05) which was similar to the
weight loss in the H1PQ animals.
Upon termination, the organs of all animals except those receiving
H1PQ appeared normal.

The lungs from the H1PQ group exhibited varying

degrees of hemorrhage ranging from scattered focal hemorrhage to
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Figure 6, Cummulative Urinary Excretion of Paraquat and Putrescine
Data are expressed as pmoles paraquat ± standard deviaton. Paraquat
in the urine of animals given 250 nmoles paraquat/hour (o) (n"3) and 500
nmoles paraquat/ hour (•) (n“3, except day seven when n*2) indicated the
occurance of steady, dose-dependent excretion with no apparent effect
due to coadministered putrescine. Likewise, putrescine administration
[either 2500 nmoles/hour <a ) (n“3) or 5000 nmoles/hour (A) (n=3)l
resulted in a dose-dependent and steady urinary excretion of putrescine
which was greater than basal putrescine excretion observed in animals
not given putrescine (®) (n“2, except day seven when nBl). There was no
observable effect on putrescine excretion due to paraquat
coadministration.
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Figure 7. Rat Body Weights at Termination
Data are expressed as grams body weight + standard deviation. Groups coded with the same letter were
not significantly different (i.e., F > 0.05) by Two-way ANOVA and subsequent Duncan's Multiple Range Test.
The FLC group mean was compared to other group means by Student's t-test. The apparent significant decrease
in body weight in the 250 nmoles paraquat/hr (LoPQ) groups was not a true decrease since the pre-operative
weights of these animals were also significantly lower than the animals given no paraquat (OFQ). Sample
sizes: n“5 per subgroup except in the 500 nmoles paraquat/hr + OFTC group (n“4).
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occasional involvement of entire lobes.

The lungs were significantly

larger (P<0.05) than lungs from animals given either OPQ or LoPQ as
evidenced by greater than doubled relative weights (I.e., organ
weight/body weight x 100) shown In Figure 8.

This weight gain was

indicative of Injury which could be associated with varying degrees of
edema, hemorrhage and vascular congestion, and/or cellular
proliferation.
Despite the normal appearance of the other organs examined, there
were some significant (P<0.05) changes observed In the relative weights
of liver and kidney as a result of paraquat treatment (Table 3).

The

relative liver weight In LoPQ animals was 1092 and 1122 (P< 0.05) of
HiPQ and OPQ groups, respectively.

In the FLC group, relative liver

weight was significantly decreased (P<0.05).

Relative liver weights of

the HIPQ groups, were not different from those of animals not given
paraquat.

The relative kidney weights of LoPQ and HIPQ rats

Increased

to 1102 and 1162 of the OPQ groups, respectively, while relative heart
weights were not different In any treatment group (Table 3).

Evaluation of hlstopathology by light microscopy
Qualitative examination of lung sections by light microscopy
revealed that lungs of rats given HIPQ had undergone changes
characteristic of paraquat Intoxication (Figure 9).

Coadministration of

putresclne offered no apparent modulation of these histological changes.
Further, putresclne administration alone had no observable effect of
lung histology.
unremarkable.

Lungs of control, LoPQ, or FLC animals were, also,

LO
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Figure 8. Relative Lung Weights
Data are expressed as the average of lung weight/body weight x 100 [+ standard deviation]. Groups coded
by the same letter were not significantly different (i.e., P > 0.05) by Two-way AN0VA and subsequent
Duncan's Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test.
There was no difference in relative lung weights due to putrescine administration. Absolute lung weights
were 1.15 - 0.12, 1.21 ± 0.16, 2.26 - 0.78, and 1.13 ± 0.05 grams for groups given OPQ, LoPQ, HiPQ, and FLC
group, respectively. Sample sizes: n“5 per subgroup except in the 500 nmoles paraquat/hr + 0PTC group (n=4).
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Table 3. Relative Weights of Liver, Kidney, and Heart*

Paraquat Dosage Rate (nmoles/hr)

Organ

0

250

500

FLC

Liver

3.11 ± 0.15a
(15)

3.37 ± 0.24b
(15)

3.14 ± 0.40a
(14)

2.92 ± 0,17c
(5)

Kidney

0.79 ± 0.03°
(15)

0.87 ± 0.10b
(15)

0.98 ± 0.17b
(14)

0.78 ± 0.06a
(5)

Heart

0.29 ± 0.01a
(15)

0.31 ± 0.03a
(15)

0.31 ± 0.03a
(14)

0.30 ± 0.01a
(5)

*Data are expressed as the average of organ weight/body weight x 100
for each paraquat group across all putresclne dosages ( ±standard
deviation). Groups coded by the same letter were not significantly
different (i.e., P >0.05) by Two-way ANOVA and subsequent Duncan"s
Multiple Range Test. There were no significant differences due to
putresclne dosage.The FLC group mean was compared to other group means by
Student’s t-test. Numbers in parentheses indicate sample size.
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Figure 9. Section of Control and Paraquat-damaged Lung
As judged by light microscopy, the lungs of LoPQ, FLC, and control
(A) rats were unremarkable. In the lungs of rats given HiPQ (B) the
walla of the respiratory bronchioles, alveolar ducts, and alveoli were
estimated to be two to three times their normal thickness, at least
partially attributable to interstitial pulmonary edema. Other,
trichrome-stained, sections confirmed an increase in collagen
deposition, suggesting stimulation of fibroblasts. Characteristic damage
to the type I alveolar epithelial cells was evidenced by proliferation
of type II alveolar epithelial cells which lined many of the alveolar
spaces. Pulmonary macrophages were increased in number, and some alveoli
contained cellular debris. There also appeared to be a Blight increase
in numbers of chronic inflammatory cells along with variable numbers of
red blood cells in the interstitium. (hematoxylin & eosin; x400)
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Paraquat and polyamlne concentrations of blood
at termination
Blood paraquat levels at sacrifice were significantly different due
to paraquat dosage (P< 0.05) with animals given HIPQ having slightly
more than twice the paraquat concentration of the LoPQ groups (Figure
10).

These blood concentrations ranged from 1.06 to 1.57 nmoles/ml for

LoPQ groups and from 2.09 to 4.87 nmoles/ml for HiPQ groups and were
comparable to the paraquat levels shown to be maintained In
representative animals over the duration of paraquat infusion (compare
Figure 5).

Coadministration of putresclne had no effect on blood

paraquat concentrations.
While putresclne infusion did result In a dose-dependent Increase
In blood putresclne concentration In the terminal blood samples,
coadmlnlstratlon of paraquat resulted In statistically significant (P <
0.05) interactive effects between putresclne and paraquat (Figure 11).
Increasing, combined doses of paraquat and putresclne appeared to
potentiate blood putresclne levels over the Increases in blood
putresclne produced by either compound alone.
Blood spermidine was significantly decreased due to paraquat
Infusion over all doses of putresclne (Figure 11).

These decreases

amounted to 31Z and 39Z for LoPQ and HIPQ, respectively and were not
significantly different from each other.

Putresclne administration also

had an effect on blood spermidine In that across all paraquat doses■
HiPTC resulted In a 34% Increase compared to animals given OFTC.
largest decrease in blood spermidine was observed In the FLC group

The
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Figure 10. Terminal Blood Paraquat Concentration
Data are expressed as nmoles paraquat/ml blood + standard
deviation. Groups coded by the same letter were not significantly
different (i.e., P >0.05) by Two-way ANOVA. There were no differences
due to putrescine coadministration. Sample sizes: n**5 per group except
in the 500 nmoles paraquat/hr + 0PTC group (n"4)•
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Figure 11. Terminal Blood Polyamine Concentration
Data are expressed as nmoles polyamine/ml blood + standard deviation. For each polyamine, groups coded
with the same letter were not significantly different (i.e., P > 0.05) by Two-way ANOVA and subsequent
Duncan's Multiple Range Test. The FLC group means were compared to other appropriate group means by
Student's t-test.
* Two-way ANOVA revealed significant interaction effects of coadministered paraquat and putrescine on
blood levels of putrescine and spermine.
Sample sizes: n°5 per subgroup except in the 500 nmoles paraquat/hr + OPTC subgroup (n“4).
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(Figure 11).

The blood spermidine concentrations in this group were

29.2Z, 42.41, and 48.7% of OPQ, LoPQ, and HiPQ groups, respectively.
Statistical analysis revealed significant interactive effects (P <
0.05) of paraquat and putrescine on blood spermine levels (Figure 11).
In the absence of paraquat, putresclne administration seemed to Increase
blood spermine levels.

Animals given LoPQ also appeared to have

Increased blood concentrations of spermine.

Putresclne coadministration

to this group did not cause any further Increases in this polyamine in
contrast to the situation in animals receiving OPQ.

Blood spermine in

the HiPQ groups shoved a generalized decrease compared to the respective
OPQ and LoPQ groups.

Normalization of lung biochemical data
Lung injury typically involves congestion, hemorrhage, accumulation
of edema fluid containing varying amounts of protein, and cellular
proliferation.

All of these factors can contribute in varying degrees

to large Increases in lung weight and protein content which can make
expression of data aa value per gram tissue or per mg protein subject to
large errors.

Because of the large increases in lung weight and total

lung protein (Figure 12) observed in the HiPQ groups, all lung
biochemical data was expressed as value per whole lung (i.e., both
lungs) in order to normalize this data to a common denominator term.

Paraquat and polyamine content in the lungs at sacrifice
The paraquat content per lung (Figure 13) reflected the
administered dose of paraquat and averaged 24.52 ± 4.72 and 55.27 ± 8.9
nmoles/lung in the LoPQ + OPTC and HiPQ + OPTC groups, respectively.

Figure 12. Lung Frotein Content
Data are expressed both as mg protein/gm tissue and mg protein/lung + standard deviation. Groups coded
with the same letter were not significantly different (i.e., P > 0.05) by Two-way AHOVA and subsequent
Duncan's Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test.
There were no significant differences due to putrescine coadministration. Sample sizes: n“5 per subgroup
except in the 500 nmoles paraquat/hr + OPTC subgroup (n*4).
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Figure 13, Lung Paraquat Content
Data are expressed as nmoles paraquat/lung + standard deviation.
Groups coded with the same letter were not significantly different
(i.e., P >0.05) by Two-way AHOVA and subsequent Duncan's Multiple Range
Test. There were no differences due to putrescine administration. Sample
sizes: n“5 per subgroup except in the 500 nmoles paraquat/hour + OPTC
subgroup (n°4).
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Further, these lung paraquat levels were higher than the respective
blood levels on the basis of a gram lung to milliliter blood comparison,
suggesting the occurrence o£ concentratlve uptake.

Coadministration of

putresclne at either dosage rate had no significant effect on lung
paraquat content In animals given LoPQ or HiPQ.
A profile of lung polyamine content is given in Figure 14.

The

administration of H1PTC resulted In a 57% increase (P<0.05) In lung
putresclne levels over those measured In animals of all treatment groups
given OPTC.

The LoPTC dose was not effective In Increasing lung

putresclne concent except In the HIPQ -f LoPTC group.

In that group,

LoPTC administration resulted In a statistically Insignificant, 27%
Increase In lung putrescine.
Although the effects of coadministered putresclne on lung paraquat
were not statistically significant, paraquat had marked effects on the
levels of lung putrescine and spermidine (Figure 14).

With HIPQ, lung

putrescine was Increased by 307% (P<0.05), 167% (P<0.05) and 621% (P<
0.05) over levels found In OPQ, LoPQ, and FLC groups respectively.

HiPQ

resulted in a 59% (P< 0.05), 97% (P<0.05), and 164% (F<0.05) Increase
in lung spermidine compared to OPQ, LoPQ, and FLC groups, respectively.
The lungs of animals given HIPQ demonstrated a 73% (P< 0.05) increase in
pulmonary OSC activity as compared to both OPQ and LoPQ animals (Figure
15).

Putresclne coadministration had no effect on lung 0DC activity.

Paraquat and polyamines In liver, kidney, and heart
The paraquat content of liver and kidney (Figure 16), though leas
than that of lung (compare Figure 13), showed a definite
dose-dependency.

Paraquat levels per dose were greatest In kidney and

Figure 14. Lung Polyamine Profile
Data are expressed as nmoles polyamine/lung + standard deviation. For each polyamine, groups coded with
the same letter were not significantly different (i.e. P

> 0.05) by Two-way AHOVA and subsequent Duncan's

Multiple Range Test. The FLC group means were compared to other group means by Student's t-teat.
* Lung putrescine content was significantly elevated (P < 0.05) over all levels of paraquat dosage by
coadministration of 5000 nmoles putrescine/hr.
** Lung putrescine content was significantly lower (P < 0.05) in the FLC group than in animals
administered paraquat.
*** Lung spermidine and spermine content of the FLC group was significantly lower (P < 0.05) than that
of animals administered 500 nmoles paraquat/hr (HiPQ).
Sample sizes: ns5 per subgroup except in the 500 nmoles paraquat/hr + OPTC subgroup (n**4).
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Figure 15. Lung Ornithine Decarboxylase Activity
Data are expressed as pinoles

liberated/lung/30 min. at 37° C + standard deviation. Groups coded

with the same letter were not significantly different (i.e., P >0.05) by Two-way ANOVA and subsequent
Duncan's Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test.
There were no significant differences due to putrescine coadministration. Sample sizes: n=5 per subgroup
except in the 500 nmoles paraquat + OPTC subgroup (n*4).
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Figure 16. Kidney and Liver Paraquat Content
Lata are expressed a3 nmoles paraquat/gm tissue + standard deviation. For each organ, groups coded with
the same letter were not significantly different (i.e., P > 0.05) by Ttao-way ANOVA and subsequent Duncan's
Multiple Range Test. There were no significant differences due to putrescine coadministration. Sample sizes:
n=5 per subgroup except int the 500 nmoles paraquat/hr + OPTC subgroup (u"4).

PUTRESCINE DOSAGE RATE
(N M O LES/m )
KIDNEYS

0□

2500 ZZ2 5000 ■

LIVER

H

250 ‘
PARAQUAT DOSAGE RATE

(n m o le s /h r)

I-

B

500

51
undetectable In heart homogenates.

Coadministration of putresdne at

any dose had no effect on paraquat levels In kidney and liver.
In the liver and kidneys, there was no significant difference in
concentration of any of the three measured polyamines between any of the
primary treatment groups (Appendix).
In the heart, putrescine administration significantly Increased the
putresclne concentration of the tissue (to 118X and 125Z of OFTC for
LoPTC and HiPTC, respectively) but there was no significant difference
In this increase due to difference In putresclne dose (Figure 17).
Putrescine administration had no effect on the heart concentration of
any other polyamine.
It Is also shown In Figure 17 that putresclne concentration in
heart tissue was significantly elevated (F< 0.05) by HiPQ an average of
28Z and 23Z over OFQ and LoPQ respectively.

Both doses of paraquat

tended to significantly decrease spermine concentration (79X and 81Z of
the OFQ groups In the LoFQ and HIPQ groups, respectively).

Changes In lung glutathione, glutathione peroxidase system
enzymes, and NADPH
Over all dosage levels of putrescine, the LoPQ treatment groups
demonstrated an elevation of total lung glutathione (TIG " reduced (GSH)
+ oxidized glutathione (GSSG)] to 134X (P< 0.05) of that measured in
animals not administered paraquat (Figure 18).

TLG levels from animals

which were given HiPQ were not different from the OPQ groups but were
125JE (P< 0.05) of that measured in the FLC group (Figure 18).
The increased TLG reported In Figure IB is essentially attributable
to increased lung GSH since there

wob

no significant change in lung GSSG

Figure 17. Heart Polyamine Profile
Data are expressed as nmoles polyamine/gm tissue + standard deviation. For each polyamine, groups coded
with the same letter were not significantly different (i.e. P > 0.05) by Two-way ANOVA and subsequent
Duncan's Multiple Range Test. The FLC group means were compared to other group means by Student's t-test.
* Duncan's Multiple Range Test indicated that all paraquat doses, the putrescine levels in the heart
were significantly increased in the animals that were administered putrescine. This effect was not dependent
on putrescine dose.
Sample sizes: n“5 per subgroup except in the 500 nmoles paraquat/hr + OPTC subgroup (n*4).
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Figure 18. Total Lung Glutathione Content
Data are expressed as pmoles total glutathione (reduced +
oxidized)/lung + standard deviation. Groups coded with the same letter
were not significantly different (i.e., P > 0.05) by Two-way ANOVA and
subsequent Duncan's Multiple Range Test. The FLC group mean was compared
to other group means by Student's t-test. There were no differences due
to putrescine coadministration. Sample sizes: n**5 per subgroup except in
the 500 nmoles paraquat/hr + OPTC subgroup (na4).
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resulting from paraquat exposure (Figure 19).

Putrescine, likewise had

no effect on lung GSSG at any dose.
Of the four glutathione peroxidase system enzymes measured in the
lungs, activities of two were not affected by any treatment.
6-PGD and GSH peroxidase (Appendix).

These were

Glucose-6-phosphate dehydrogenase

(Figure 20) and GR (Figure 21), however, demonstrated significant
treatment-induced alterations in activity.
The total activity of G6PD in lung showed a paraquat dose-dependent
induction.

The activity of LoPQ and HiPQ groups increased to 1131 and

159% of control, respectively across all putresclne doses.

The

induction of lung G6FD in the HIPQ groups is especially significant
because it was 266Z of the activity measured in the comparably fed, FLC
group which showed significant loss of G6PD activity.

Putrescine

administration had no effect on G6PD activity.
Total lung GR activity was also Induced by paraquat administration.
However, the LoPQ groups demonstrated a greater increase (132Z of OFQ
groups) in lung GR activity than did the animals in the HiPQ groups
(117% of OPQ groups).

As with G6PD, GR activity was not altered by

putresclne administration.
• Administration of paraquat resulted in a dose-dependent decrease in
NADPH, irrespective of putresclne dosage (Figure 22).

The large

standard deviations of group means probably precluded detection of
significant differences in lung NADPH between OPQ and LoPQ groups (NADPH
in the LOPQ groups was 82% of OPQ).

Despite the high variation the

decrease in lung NADPH observed in the HIPQ animals (57% of OPQ groups)
was statistically significant (P<0.05).
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Figure 19. Lung Oxidized Glutathione Content.
Data are expressed as pmoles GSSG (as GSH equivalents)/lung +
standard deviation. There were no significant differences due to any
treatment. Sample sizes; n“5 per subgroup except in the 500 nmoles
paraquat/hr + OPTC subgroup (n**4).
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Figure 20. Lung Glucose-6-phosphate Dehydrogenase Activity
Data are expressed as pmoles NADP reduced/min./lung at 37° C + standard deviation. Groups coded with
the sane letter were not significantly different (i.e., P > 0.05) by Two-way ANOVA and subsequent Duncan’s
Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test. There were no
significant differences due to putrescine coadministration. Sample sizes: n“5 per subgroup except in the 500
nmoles paraquat/hr + 0PTC subgroup (n°4).
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Figure 21. Lung Glutathione Reductase Activity
Data are expressed as pmoles NADPH oxidized/rain./lung at 37° C + standard deviation. Groups coded with
the same letter were not significantly different (i.e., P > 0.05) by Two-way ANOVA and subsequent Duncan's
Multiple Range Test. The FLC group mean was compared to other group means by Student's t-test. There were no
significant differences due to putrescine coadministration. Sample sizes: n*5 per subgroup except in the 500
nmoles paraquat/hr + OPTC subgroup (n=4).
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Figure 22. Lung NADPH Content
Data are expressed as nmoles NADPH/lung + standard deviation. Groups coded with the same letter were
not significantly different (i.e., P > 0.05) by Two-way ANOVA and subsequent Duncan's Multiple Range Test.
The FLC group mean was compared to other group means by Student* t-test. There were no significant
differences due to putrescine coadministraion. Sample sizes: n=5 per subgroup except in the 500 nmoles
paraquat/hour + 0PTC subgroup (n"4).
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Chapter 4
Discussion

Paraquat Administration by osmotic pump
Toxicologlcal studies of paraquat in animals have typically
employed administration of a single toxic dose of the herbicide by
various routes and have evaluated the resulting physiological and
biochemical effects.

Exceptions to this generalization include the

experiments of Bus et al. (1975) that looked at effects on the GSH
peroxidase enzyme system in rats exposed for three weeks to 100 ppm
paraquat in their drinking water* and Dey et al. (1982) which examined
the disposition of paraquat in rats after 19 days of exposure to
paraquat administered subcutaneously via osmotic pump.
The resultB reported here demonstrate the effectiveness of
continuous intravenous infusion of paraquat from Alzet

osmotic pumps

in rapidly achieving and maintaining for an extended period of time* a
stable blood concentration of paraquat.

Steady paraquat blood levels

were achieved by the first sampling point of 18 hours demonstrating its
short blood half life (20-30 minutes; Sharp et al.* 1972).

Absorbed

paraquat is excreted almost exclusively by the kidneys (Sharp et a l .,
1972).

Approximately 80% of the paraquat administered In this study was

excreted In the urine* therefore as much as 20% of the total paraquat
dose was unaccounted for and likely retained in the body.

Similar

results were achieved with putresclne coadministration but the blood and
urine levels measured did not seem commensurate with the administered
dose.

The low blood levels of putrescine were indicative of a short
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blood half~ll£e for this polyamlne, resulting either from Its rapid
degradation or a large volume of distribution.
The normal appearance and behavior of animals given the lower
dosage of paraquat (250 nmoles/hr for seven days ■ LoPQ), coupled with a
lack of observable lung histological changes, establish the usefulness
of this experimental model In the evaluation of low-level, continuous
exposure to paraquat.

Manifestations of paraquat toxicity such as

anorexia and hypoxia and the Involvement of toxicity to other organs
such as the kidney, which could result In altered paraquat excretion did
not occur.

This type of exposure would lend Itself well to studies of

the Initial biochemical leBlon(a) occurring In

paraquat toxicity and/or

the development of adaptive/reparative responses of the lung due to
prolonged paraquat exposure.

The rapid clearance of paraquat from the

blood restricts fcn vivo studies of pulmonary accumulation of paraquat
conducted with single doses (Det et al., 1982).

Achievement of

prolonged, steady-state blood levels of paraquat would facilitate
kinetic studies of Its pulmonary accumulation, In vivo, and factors
which may modulate this process.

Dose-dependency of lung paraquat content
The absence of any sign or symptom of intoxication In LoPQ rats and
the normal appearance of their lungs upon histological evaluation,
contrasted sharply with the rather characteristic pulmonary toxicity
that developed In animals given 500 nmoles paraquat/hr (HIPQ).

This

reflected the dose-dependent differences between HIPQ and LoPQ groups in
the lung paraquat content attained and, thus, demonstrated the direct
relationship between lung paraquat content and the development of
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pulmonary toxicity.

A total, cumulative paraquat does of 25.7 mg/kg and

51.4 mg/kg was administered to LoPQ and HIPQ animals, respectively, over
the infusion period.

Zn both cases the total dose exceeded the

intravenous, single-dose LD^ q (21 mg/kg; Sharp et al., 1972).

The

contrasts in the rapid development of toxicity In rats given a single,
LD^ q dose with the animals of this study, demonstrate the importance of
paraquat blood levels and the length of time those levels are maintained
in achieving toxic paraquat levels in the lung.
The greater paraquat concentration in the lungs, as compared to Che
blood with bath doses of paraquat, supported the occurrence of a
concentrative uptake process.

The fact that the lung content of

paraquat was blood concentration-dependent, suggests that if the
pulmonary accumulation of paraquat did occur by the energy-requiring,
saturable uptake system described by Rose et al. (1974), paraquat
concentrations achieved at the site of pulmonary uptake were not
sufficient for the uptake system to operate at Its

If the site of

paraquat uptake is, indeed, the alveolar epithelium, then the means by
which Intravascularly administered paraquat would become available to
this site would largely be by diffusion from blood through the vascular
endothelium (Rannels et a l ,, 1985).

If dlffuslonal equilibrium was

achieved and the concentration of paraquat at the pulmonary uptake site
was equivalent to the blood concentration, those concentrations would
have been 1.34 pM (1.34 ± 0,05 nmoleB/ml blood) and 2.98 pM (2.98 ± 0.26
nmoles/ml blood) in rats given LoPQ and HIPQ, respectively.

Both of

these concentrations would have been well below the 70 pH K determined
*
tu
by Smith et al. (1974) for paraquat uptake in their lung slice system.
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Lack of effect of putresclne coadminlatration
on lung paraquat content
Among the hypotheses addressed by this study was the ability of
coadmlnlBtered putresclne to decrease accumulation of paraquat by the
lung.

While the results suggested the occurrence of concentrative

pulmonary uptake of paraquat, there was no indication after seven days
of exposure that coinfusion of putresclne, at the dosages employed, was
able to effect significant reductions In lung paraquat content.

This

may have been due to a failure to achieve blood levels of putresclne
sufficient to provide effective competition with paraquat at the uptake
site.

This is supported somewhat by the fact that only the B1FTC dose

resulted In significant elevations of lung putresclne that could be
attributed to putrescine administration alone.
Smith and Wyatt (1981) found that uptake of paraquat by lung slices
from an Incubation medium

was Inhibited approximately 50X by an

equlmolar (10 pM) putrescine content.

Therefore, it might seem that the

blood putrescine levels found In this study (resulting from putresclne
administration alone), which were at least double the blood paraquat
concentration, should have been effective In inhibiting
paraquat accumulation.

pulmonary

It Is, however, difficult to relate the data

from the In vitro lung slice system to the intact animal model. In the
lung slice, the site of uptake (alveolar epithelium) was directly
exposed to the compounds in question, while in vivo, the compounds are
separated from the site of uptake by the vascular endothelium and,
therefore, have a barrier to cross before they can arrive at that site
and be actively accumulated*

Also, while the relative concentrations of
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putresclne and paraquat can be readily determined In blood* that
relationship cannot be accurately measured at the uptake site and cannot
be assumed to be the same as that found In blood.

Therefore, It is not

possible to compare the relative concentrations of putresclne and
paraquat used In an in vitro incubation medium that result In inhibition
of paraquat uptake vith that which may, or may not, have been achieved
at the pulmonary uptake site, In vivo.
The only other experimental model available for useful comparison
to the present study Is that of Rannels et al. (1985) which showed that
In the Isolated rat lung perfused with a blood-free medium, a 50 (jM
concentration of methylglyoxal bis (guanylhydrazone)

(MGBG) added to the

perfusate containing one uM paraquat effectively Inhibited pulmonary
paraquat accumulation.
polyamine analogue

The 50-fold excess of the nonmetabolizable

compared to perfusate paraquat content In the

isolated lung study, far exceeded the blood putrescine/paraquat ratios
attained In the present Investigation.

This difference may explain the

contesting results regarding Inhibition of pulmonary uptake of paraquat.
Since putresclne Is a metabolizable compound, It may be that
greater blood levels of a nonmetabolizable putresclne/polyamine analogue
such as HGBG could be achieved, In vivo than Is possible with
putrescine.

Because this compound was effective In Inhibition of

pulmonary uptake of paraquat In the perfused lung (Bannels et al.,
1985), it*might also prove effective, in vivo, If adequate blood
concentrations relative to paraquat can be safely maintained.
The absence of observable Inhibition of lung accumulation of
paraquat in this study also contrasts with a similarly conducted
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investigation (Dunbar et al., 1965) that suggested in vivo inhibition of
pulmonary paraquat uptake by coadministered

putrescine might occur.

There was a major difference between the two studies which may have
contributed to the discrepancy.

In the previous study (Dunbar et al.,

1985) putresclne was administered subcutaneously, at a rate of 9317
nmoles/hr (i.e. 1500 pg/hr).

Here, putresclne was given I.V. rather

than S.G. to avoid any variation in blood level due to absorption
effects and metabolic degradation by extrapulmonary tissues (e.g.
first-pass liver metabolism) before becoming available to the lung.

The

dose was also decreased from that given S.G. in anticipation of possible
toxic effects resulting from such a large I.V. dose.

Blood putrescine

levels were not measured in the previous experiments and, therefore,
comparisons of blood concentrations between these two studies cannot be
made.

But, the apparently lower lung paraquat levels observed in the

previous study with putrescine coadministration suggests that the
putresclne dosage rates employed previously may have resulted in higher
blood putresclne levels than were reached in the present study, despite
the difference in route of administration.
A lack of sufficient blood concentrations of putresclne to result
in observable inhibition of paraquat accumulation could very well have
been compounded by the fact that erythrocytes can accumulate putrescine,
spermidine, and spermine (Moullnoux et al., 1984) and as much as 901 of
blood polyamines can be transported in the red cell (Cohen et al,,
1976).

Unfortunately, due to sample volume considerations, putresclne

and polyamlne levels were determined in whole blood rather than plasma,
therefore, actual plaBma levels of putresclne available for diffusion to
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the uptake site are not knovn.

This was not a problem for paraquat

since blood concentrations of this compound are equivalent to plasma
levels (Sharp et al., 1972).

Effects of paraquat on tissue polyamlne metabolism
Blood concentrations of putresclne were more
given Increasing doses of paraquat

elevated In animals

than they were, due to putresclne

administration alone. The higher levels of blood putresclne In these
rats

might have been expected to be more effective In Inhibition of

pulmonary paraquat uptake.

However, these additional Increases in blood

putresclne probably resulted as an adaptive or toxic response in the
lung to already accumulated paraquat.

Such elevations In the levels of

polyamines In extracellular fluids (I.e., blood, plasma, and urine) are
generally believed to reflect pathological conditions involving cellular
proliferation and growth (Russel et al., 1983) (e.g. cancer, cystic
fibrosis, psoriasis).

The paraquat-induced Increases in blood

putresclne observed in this study, likewise, probably reflect Increased
putrescine production in paraquat-affected tissues.

On the basis of

this assumption, by far the largest contributor to blood putresclne (of
the tissues analyzed) would have been the lungs, especially those of
animals given HIPQ which demonstrated evidence of type II cell
proliferation and exhibited a marked elevation of putrescine.
Paraquat-induced increase in lung spermidine suggested induction of
subsequent steps of the polyamlne biosynthesis pathway, although
activities of S-adenosylmethlonine decarboxylase (SAMDC) or spermidine
synthetase were not directly measured.

In contrast to putresclne,

elevations In lung spermidine were not reflected

sb

an Increase in blood

66
spermidine.
animals.

Blood spermidine was actually decreased In paraquat-exposed

The decreased blood spermidine found In the HIPQ group might

be explained by poor nutritional status alnce a similar decrease
observed In the FLC group.

wsb

A decrease In blood spermidine was also

measured In the LoPQ group which would not have been explained by food
limitation.

It Is possible that LoPQ produced an effect on metabolism

which caused a decrease In blood spermidine similar to that resulting
from nutritional Impairment.
The marked elevations In lung putrescine, spermidine, and ODC
activity resulting from exposure to HIPQ for seven days were similar to
those observed by Hacker et al. (1983) in lungs of rats exposed to 85%
oxygen (classically, a tolerance-producing concentration) for up to
seven days, followed by subsequent exposure to 100Z oxygen for up to 10
days.

The data are also consistent with the findings of Thet et a l .

(1984) who found elevations In ODC activity, putrescine, spermidine, and
spermine In rat lungs recovering from oxygen-induced Injury.

The

comparable effects of paraquat and hyperoxla on lung ODC and polyamines
demonstrate yet another similarity in the lung's biochemical response to
paraquat exposure and hyperoxla.

They are not necessarily Indicative of

the possible similarity in toxic mechanism of paraquat and oxygen, but
could rather be a generalized response to tissue Injury resulting in, or
associated with, cellular proliferation and growth.
Cellular proliferation in the lung was observed in both this study
and that of Thet et al. (1983).

Cellular proliferation

and stimulation

of polyamlne synthesis were shown to be closely related occurrences when
Thet et al. (1983) demonstrated that the proliferative process could be
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attenuated by an inhibitor of ODC, difluoromethylomlthlne (DFMO),
resulting in overall Inhibition of the polyamlne biosynthetic pathway.
This suggested a modulating role for polyamines In repair of lung
subsequent to oxygen damage.

Similarly, the Increases in lung

polyamines and ODC In HIPQ rats may reflect stimulation of repair
mechanisms.

The changes In polyamlne metabolism might also have played

a role In the adaptive Induction of lung GSH, G6PD, and GR via Its
regulatory role in RNA and protein synthesis (Bachrach, 1973).

It is

also possible that increased lung putrescine directly enhanced activity
of G6PD as demonstrated by Dodds (1986), in vitro.
While proliferation of endothelial and epithelial cells may be
Important in the repair of lung Injury, excessive proliferation of
interstitial cells can have severe deleterious effects (Hacker et al.
1983). In the case of paraquat intoxication this may be expressed as the
characteristic, typically lethal, pulmonary fibrosis.

Hacker et a l .

(1983) proposed that antimetabolites of polyamlne synthesis may be
useful for suppression of excessive cellular proliferation after lung
Injury which may otherwise result In interstitial pneumonitis or
fibrosis.

Similarly, the fact that lungs of rats exposed to HIPQ

exhibited large Increases In putresclne and spermidine associated with
their observed state of cellular proliferation and beginning collagen
deposition, suggests that such an intervention may be useful in
combating the specific problem of paraquat-induced pulmonary fibrosis.
Except for an apparent effect of HIPQ on heart polyamines, the lack
of effect of paraquat on the polyamlne profile of any other organs
analyzed would appear to be further demonstration of the known
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selectivity of paraquat toxicity for the lung.

From the data It would

appear that this selectivity Is, In large measure, a reflection of the
retention of relatively high levels of paraquat within the lung.
Additionally, since significant changes In ODC and lung polyamines
occurred only In the HIPQ animals. It suggests that those alterations
resulted more as a response to cell damage than a direct response to
paraquat exposure.
Generalizations concerning the diagnostic value of tissue polyamlne
profiles have been made (Russell, 1983).

Elevations In ODC and

putresclne occur In tissues which have been stimulated to Initiate cell
proliferation.

Increased spermidine levels are associated with the next

step In the proliferative process, that Is, increased RNA content and
actual cell replication.

Elevations In tissue spermine are related to

the process of differentiation.

On the basis of these generalizations,

the polyamlne profile of the HIPQ lungs Indicates that these lungs were
in the process of cellular proliferation which Is consistent with their
hlstopathology.
The Increase in heart putresclne concentration resulting from HiPQ
Infusion was very Interesting In that It may not have been a direct
effect of paraquat on the heart. Itself.

Russell et al. (1971) reported

that experimental constriction of the pulmonary artery of rabbits to
32-42Z of original diameter resulted In growth of the right ventricle,
which was preceded and accompanied by Increases in ODC and SAMDC
activity and putrescine, spermidine, and spermine levels.

The

appearance of the lungs of animals given HiPQ suggests that the animals
could have experienced pulmonary hypertension, thus, putting stress on

69
the right ventricle o£ the heart.

The increased levels of putresclne in

the heart of these animals may* therefore, reflect the early stages
(i.e., prior to actual growth since no differences in heart weights were
noted) of stress-induced cardiac hypertrophy.
Heart putrescine content was also increased in all animals
administered putrescine.

Although these increases were small and could

have resulted from blood contamination of the tissue preps they did
prove to be statistically significant due to the normally low levels of
putresclne found in the heart.
While the decrease in heart spermine (and hence increased
spermidine/spermine ratios) observed in these animals resembles the
occurrences in regenerating rat liver (Ralna et al., 1966) It contrasts
with the increased spermine levels accompanying stress-induced cardiac
hypertrophy (Russell et al., 1971).

The discrepancy between these two

results may be due to differences in etiology of the two stresses (i.e.,
mechanical constriction of the pulmonary artery versus pulmonary
obstruction as a result of chemical intoxication) or a species
difference.

Additionally, the fact that lung spermine was also

decreased in the LoPQ animals in the apparent absence of any myocardial
stress suggests that paraquat had some effect on this polyamlne in the
heart that was not completely attributable to pulmonary hypertension
resulting from lung damage.

Perhaps, for example, the activity of

cardiac spermine synthetase might be especially sensitive to destruction
by paraquat-generated free radicals.
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Effects on lung glutathione and glutathione peroxidase system enzymes
The results of Investigations of ozone's pulmonary toxicity led
Chow and Tappel (1972) to propose that activities of GSH peroxidase
system enzymes (GSH peroxidase, GR, and G6PD) are increased In response
to oxidant stress.

Likewise,

Kimball et al. (1976) found Increased

lung levels of GSH and total nonprotein sulfhydryl and increased
activity of GSH peroxidase, GR, and G6PD In rats exposed to 90% and 85%
oxygen for seven and 14 days.

As is the case for prolonged ozone and

oxygen exposure, the Increase of pulmonary G6PD, GR, and GSH levels
reported here may have occurred, In part, In response to superoxide
radical-mediated toxic reactions of paraquat (reviewed by Bus and
Gibson, 1984).

Similar increases of lung G6PD and GR activities were

reported by Bus et al. (1976) in rats exposed to 100 ppm paraquat In
drinking water for three weeks.

The fact that the activity of GSH

peroxidase was not increased In either the present study or that of Bus
et a l . (1976) however, contrasts with the Increased activity of this
enzyme observed In experiments involving exposure to ozone (Chow and
Tappel, 1972), oxygen (Bus et al., 1976); (Kimball et al., 1976); Cross
and Last, 1977); (Ospltal et al., 1983), or 48 hours after a single
toxic dose of paraquat (Reddy et al., 1977).

The lack of a

paraquat-induced increase In lung GSH peroxidase activity while
activities of the other enzymes attributed to the GSH peroxidase system
are increased cannot be conclusively explained. It is possible that the
dosage rates of paraquat employed in this Investigation did not result
in production of H j O j and/or lipid hyperoxides at rates
stimulate Induction of GSH peroxidase.

high enough to
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Generally, activity of G6PD and turnover of the pentose phosphate
pathway, are increased In response to Increased cellular demand for
NADPH. Along with generation of oxygen-free radicals, NADPU depletion Is
the major biochemical event, stemming from the "redox cycling" of
paraquat In lung cells.

In this experiment an Increased demand for

NADPH could have resulted from Increased consumption of NADPH in the
enzymatic reduction of paraquat, in GR-catalyzed reduction of GSSG, and
an Increase in turnover of reductive biosynthetic pathways requiring
NADPH (e.g. lipid biosynthesis).

Additionally, an Increased turnover of

the pentose phosphate pathway would be expected to provide more
rlbose-S-phosphate as substrate

for nucleic acid synthesis and repair*

The ability to maintain NADPH-dependent biosynthetic pathways and
supplies of nucleic acid precursors would be vitally important in
reparative/adaptive processes of the lung.
Oxidized glutathione has also been demonstrated to have a
regulatory role in the activity of G6PD (Eggleston and Krebs, 1974)
which is mediated by a thiol transferase-catalyzed formation of mixed
disulfides between the enzyme and GSSG (Watanabe et al,, 1972; Isaacs
and Binkley, 1977a and 1977b).

In this regard, Keeling et al. (1982a

and 1982b) reported Increased levels of lung-mixed disulfides as a
result of exposure of rats to paraquat and postulated that excess GSSG
produced as a result of paraquat-generated oxidant stress would react
with protein sulfhydryls to form glutathlone-protein disulfides.

This

would explain their findings of increased levels of mixed disulfides
while GSSG levels remained constant.

Formation of similar mixed

disulfides between glutathione and G6PD could result in Increased
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activity of the enzyme (Hstanabe et al., 1972; Isaacs and Binkley, 1977a
and 1977b) and hence explain their observed increase in turnover of lung
pentose phosphate pathway.
Results similar to those of Reeling et al, (1982b) are reported
here. Despite the presumed oxidant stress Imparted by paraquat, there
was no observable change in lung levels of GSSG at either doBage
employed.

Although levels of glutathlone-proteln mixed disulfides were

not measured in this study, an increase in their production may have, as
in the studies of Keeling et al. (1982b), explained the lack of a net
increase in lung GSSG levels.

If an increase in these mixed disulfides

did occur, they likely contributed to the paraquat-induced Increases in
lung G6PD and GR.
Besides mixed disulfides serving as a "hidden" form of GSSG,
another factor which may have contributed to the lack of accumulated
lung GSSG was that the rate of GSSG production may never have exceeded
the paraquat-enhanced capacity of GR to reduce it back to GSH.

Also,

limiting the cellular accumulation of GSSG is its leakage out of the
cell.

Such efflux of GSSG has been demonstrated in isolated,

paraquat-perfused rabbit-lungs (Dunbar et al., 1984) and may occur In
vivo, as well.
Polyamines may be effective antioxidants as a result of their
ability to scavenge superoxide anion (Vanella et al., 1979).

Khanna et

a l . (1982) demonstrated an apparent protective effect of putrescine and
polyamineB administered prior to a single dose of paraquat. They

showed

that putreaclne inhibited the stimulation of lipid peroxidation by
paraquat and attenuated the subsequent increase in superoxide dlsmutase

activity In the lung.

They attributed their findings primarily to the

proposed free radical scavenging ability of the polyamines.

Putresclne

haB also been demonstrated to stimulate activity of G6PD In vitro (Dodds
et al., 1986).

In thie study, however, exogenously administered

putrescine was not able to alter the paraquat-induced changes In the
measured lung biochemical parameters either through attenuation of
oxidant stress, direct modulation of enzyme activities, or Inhibition of
paraquat accumulation.
The biochemical responses of the lungs to paraquat exposure that
occurred In this Investigation could have

resulted from

reparative/adaptive proliferation of certain cell populations with
normally high metabolic capacities and/or normally higher levels of
these particular biochemical systems. For example, type II epithelium
and

non-clliated bronclolar epithelium ( d a r a cells) are endowed with

higher metabolic capacity than differentiated type I cells and airway
lining cells.

Alternatively or concomitantly, the increases In GSH,

G6PD, GR, and polyamines could have occurred at the molecular level
through stimulation of new synthesis of these molecules.
biochemical changes

Many of the

observed in the HiPQ animals may have resulted from

lung damage with subsequent proliferation of type II cellB.

Since no

such shift in cell populations was observed in lungs of LoPQ animals,
the measured Increases in GSH, polyamines, and measured enzyme
activities in the lungs of rats In these groups were probably the result
of increased GSH and enzyme synthesis or enzyme activation by existing
cells.

It is not known whether or not this occurred in direct response

to paraquat-generated oxidants and increased oxidation of NADPH or as a
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result of Initiation of reparative processes In response to sublethal
cell damage.
By whatever mechanlam(s) paraquat-induced Increases In lung
biochemical parameters occurred) these changes Imply that the lungs had
an Increased capacity for defense against paraquat toxicity mediated by
paraquat-generated oxygen free radicals by virtue of Increased lung GSH
and higher activities of G6PD and GR.
The pulmonary damage observed In the rats given H1PQ, however)
suggests that enhancement of lung GSH, G6PD, and GR was, in fact, of
little benefit in prevention of the manifestation of paraquat's lung
toxicity.

There are several possibilities which may explain the

apparent Inability of this stimulated lung antloxldant system to protect
against paraquat damage.

First, it is possible that at the higher

paraquat infusion rate, and therefore, higher lung paraquat levels,
paraquat-induced production of oxygen-free radicals exceeded the
antloxldant capacity of GSH system.

Although the rats given LoPQ

exhibited no observable damage (at the level of light microscopy). It is
possible that if the infusion of paraquat at the lower rate had
continued, the lung paraquat content would likewise have reached levels
which could have overwhelmed this antioxidant mechanism, resulting In
lung damage.

Second, it is also possible that an Increase in components

of the GSH peroxidase system serveB no real functional advantage in
adaptation to oxidant stress, especially in the absence of Increased
activity of GSH peroxidase itself.

The Importance of Increased activity

of GSH peroxidase system enzymes in the development of Increased
tolerance to oxygen toxicity has recently been called to question by

Ospital et al. (1983).

They found that increases In activities of G6PD,

GR, GSH peroxidase, and nonprotein sulfhydryls In rat lungs after
exposure to 85Z oxygen did not correlate with the resulting tolerance to
subsequent challenge with 100% oxygen.

This, they pointed out, would

not preclude the Importance of this system In protection of tissues from
normally present levels of oxidants,

ffhlle It Is true that rats In this

Investigation given LoPQ did not exhibit signs of lung damage it Is not
possible to determine from these data whether this absence of damage was
related to any protective effect imparted by Increased lung G6PD, GR,
and GSH.

This question might be resolved by coadmlnlBtratlon of

buthionlne sulfoxlmlne to inhibit GSH synthesis and/or
l»3-Bis(2-chloroethyl)-l-nltrosourea (BCNU) to inhibit the activity of
GR and determination of whether these interventions result In lung
damage from an equivalent dose of paraquat.
A third explanation of the apparent inability of Increased activity
of this antloxldant system to protect from manifestations of
paraquat-induced lung damage could be that this is not the primary
antloxldant mechanism employed in the defense against paraquat-generated
free radicals.

Indeed, K ombrust and Mavis (1979) proposed that vitamin

E was the major cellular antioxidant protecting against peroxidative
membrane damage, olnce they were able to correlate resistance to in
vitro peroxidation of mlcrosomes from various tissues to vitamin E
content.

Bus tst al. (1976) demonstrated that acute paraquat treatment

resulted In decreased lipid soluble antioxidants (e.g. vitamin E) In
mouse lung but had no effect on lung GSH content.

This might suggest

that In lung vitamin E may play a more significant role in
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detoxification of paraquat-generated oxygen radicals.

However, these

experiments contrast with the present Investigation In that Bus et a l .
(1976) used mice and acute paraquat exposure and are, therefore
difficult to equate with the results obtained from rats given long-term
paraquat infusion.
Lastly, the apparent lack of protection of the lungs from paraquat
damage by increased G6PD, GR, and GSH suggests that the primary
mechanism of lung paraquat toxicity Involves more than lipid
peroxidation and other free radical-mediated reactions.
the

For example,

ability of paraquat to stimulate consumption of NADPH described

above was readily apparent In Che lungs of H1PQ animals.

Similar losses

of rat pulmonary NADPH occurring as a result of paraquat exposure have
been demonstrated by Hitachi et al. (1977) and Keeling and Smith
(1982b).

Depletion of lung NADPH Is often proposed as one of the

primary mechanisms of paraquat toxicity (Boyd, 1982).

In light of this,

it is Interesting that depletion of lung NADPH was demonstrated only in
rats given H1PQ and that those were the only animals exhibiting
morphological evidence of paraquat-induced lung damage.

This apparent

relationship between NADPH loss and lung cell damage was also observed
by Keeling and Smith (1982b) in rats following subcutaneous, single-dose
paraquat.

Despite the similar observed relationship between lung cell

damage and loss of NADPH in this study, the data do not support a
cleorcut cause-effect relationship.

That Is, did NADPH depletion result

in cell damage or was NADPH depletion the result of the death or
metabolic Impairment of cells?
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Additional demand on NADPH-producing aystens might have been
incurred In the lungs of the H1PQ rats due to their poor nutritional
status.

It was apparent from the FLC group that limitation of food

consumption could result in a similar decrease in lung NADPH.

The loss

of NADPH In this latter group# however# was associated with a
significant decrease In lung G6PD activity while the decreased NADPH in
the H1PQ group occurred even though these animals exhibited the most
marked Increase in lung G6PD.

This might# therefore# reflect a

decreased availability of glucose-6-phosphate for passage through the
pentose phosphate pathway due to impaired nutrition.
Even though lipid. peroxidation may not be the primary mechanism of
paraquat toxicity# the loss of NADPH In the lungs of animals given HiPQ
coupled with the possible insufficient elevation of lung GSH (although
It was elevated over the levels of the Food-limited Controls) could
possibly have contributed to subsequent peroxidation of membrane lipids
which could then have been a factor in paraquat toxicity.

Indeed, it

has been demonstrated that lipid peroxidation does not occur, in vivo#
until GSH and NADPH are depleted (Yaunes and Siegers, 1981).

CHAPTER 5
Conclusions

Continuous, intravenous infusion of paraquat from a surgically
implanted osmotic pump appears to be an effective method for study of
long-term effects of this herbicide.

It has an advantage over other

routes of administration in that it avoids variable absorption effects
and eliminates the peaks and valleys in blood concentration vhich
with singlet repeated Intravenous doses.

occur

Thus, rapid attainment of a

steady-state blood level of the compound can be achieved.

Paraquat

administration rates and durations can be selected, as the seven-day
LoFQ employed in this investigation exemplifies, vhich will not result
in overt pulmonary toxicity or Involve other organs. It is then possible
to study the more Bubtle biochemical and morphological alterations which
are a direct response to paraquat.

These changes

may be indicative of

an early adaptive response and/or the first, critical steps in a more
slowly developing pulmonary toxicity.
This experimental model should also prove useful in studies of the
mechanism of pulmonary paraquat accumulation and interventions
potentially useful in limiting this process.

Despite the ability of

putresclne and MGBG to Inhibit uptake of paraquat into lung slices and
the perfused lung, respectively, continuous intravenous coadministration
of putresclne at dosage rates up to 20 times that of paraquat did not
result in a decrease in terminal (Beven day) lung paraquat content in
thlB study.

The lack of inhibition of pulmonary paraquat uptake

reported here may have resulted from maintenance of insufficient
putresclne

at the uptake site relative to paraquat concentration.
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The Increases In activities of lung G6PD, GR, and TLG are
consistent with the proposed similarity of paraquat toxicity to that of
oxygen.

They are probably attributable to paraquat's ability to produce

superoxide anion as a result of "redox cycling" between parent compound
and a paraquat free radical.

Despite the presumed importance of GSH and

activities of enzymes of the GSH peroxidase system In protection front
oxidant stress, the lungs of H1PQ animals exhibited lung damage typical
of paraquat. This, plus the apparent inability of the lungs to Increase
activity of GSH-peroxldase itself, seems to contradict the importance of
GSH and

GSH peroxidase system enzymes in protecting against

paraquat-induced oxidant stress and the relative Importance of
paraquat-generated oxidants in development of pulmonary toxicity.

The

fact that HADPH is decreased significantly only in the damaged lungs of
the H1PQ group may be supportive of a primary role of NADPH depletion in
development of the pulmonary toxicity of paraquat.
The paraquat-induced alterations in lung polyamine content and
activity of ODC (in HiPQ rats) are, likewise, similar to those reported
to occur as a result of exposure to hyperoxla and in recovery from
oxygen-induced lung damage. Since changes in ODC activity and lung
polyamines occurred only in the HIPQ animals, it suggests that these
alterations resulted as a non-specific response to paraquat-induced lung
damage.

The changes in lung polyamines may represent a reparative

response to this damage which, if excessive, may contribute to
subsequent flbrotic changes.

This Is believed to be the first report of

such paraquat-Induced effects on the lung polyamlne system in vivo.
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APPENDICES

A. Liver and Kidney Polyamine Profile*

Paraquat Dosage Rate (nmoles/hr)

Organ

Liver

Kidney

0

250

500

FLC

Putrescine

74 ± 40
(15)

64 ± 30
(15)

70 ± 35
(14)

37 ± 11
(5)

Spermidine

293 ± 59
(15)

351 + 76
(15)

318 ± 76
(14)

234 ± 30 a
(5)

Spermine

412 ± 83
(15)

367 ± 55
(15)

350 ± 76
(14)

295 ± 74
(5)

Putrescine

47 ± 23
(15)

48 ± 20
(15)

90 ± 46
(14)

21 ± 5
(5)

Spermidine

294 ± 54
(15)

301 ± 64
(15)

275 ± 73
(14)

183 ± 3 1 a
(5)

Spermine

422 ± 98
(15)

372 ± 92
(15)

331 ± 110
(14)

219 ± 53
(5)

Polyamine

*Data are expressed as nmoles polyamine/gm tissue ± standard deviation. Two-way ANOVA revealed no
significant differences in liver or kidney polyamines resulting from any main treatment. Numbers in
parentheses indicate sample size.
a Student's t-test indicated that both liver and kidney spermidine was significantly decreased
(P < 0.05) in the FLC group compared to all other groups.

B. Activities of Lung 6-phoshogluconate Dehydrogenase and Glutathione Peroxidase*

Paraquat Dosage Rate (nmoles/hr)

0

250

500

FLC

6-phosphogluconate dehydrogenase

3.24 ± 1.28
(15)

4.35 ± 0.41
(15)

4.58 ± 2.28
(14)

2.68 ± 0.09
(5)

Glutathione Peroxidase

6.15 ± 0.85
(15)

5.93 ± 1.18
(15)

5.83 ± 1,44
(14)

5.59 ± 0.44
(5)

Enzyme

*Data are expressed as umoles HASP reduced/min./lung or NADPH oxidized/min./lung ± standard
deviation for 6-PGD and GSH peroxidase, respectively. Measurements were made at 37s C. Two-way ANOVA
revealed no significant differences due to any main treatment. Numbers in parentheses indicate sample
size.
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